Regulation of the human atrial myosin light chain 1 promoter by Ca 2+-calmodulin-dependent signaling pathways

FASEB Journal

Volumn 19, Issue 6, 2005, Pages 503-511

  Woischwill, Christiane ^a   Karczewski, Peter ^a   Bartsch, Holger ^b   Luther, Hans Peter ^b   Kott, Monika ^a   Haase, Hannelore ^a   Morano, Ingo ^a,b  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Atrial myosin light chain; Ca2+ signaling; H9c2; Promoter regulation

Indexed keywords

CALCIUM ION; CALMODULIN; CYCLOSPORIN A; HUMAN ATRIAL MYOSIN LIGHT CHAIN 1; ISOENZYME; LUCIFERASE; MYOSIN LIGHT CHAIN; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PROTEIN KINASE (CALCIUM,CALMODULIN); PROTEIN KINASE C; TRANSCRIPTION FACTOR NFAT; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENETIC TRANSFECTION; HEART HYPERTROPHY; HEART MUSCLE CELL; HUMAN; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL TRANSPORT; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CALCIUM; CALMODULIN; CELL LINE; CELL NUCLEUS; EMBRYO; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENOTYPE; HEART; HUMANS; IMMUNOBLOTTING; ISOENZYMES; LUCIFERASES; MYOCYTES, CARDIAC; MYOSIN LIGHT CHAINS; NFATC TRANSCRIPTION FACTORS; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; RATS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; VASOPRESSINS;

EID: 16344367572     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.04-2201com     Document Type: Article

References (33)

1. Lowey, S., and Risby, D. (1971) Light chains from fast and slow muscle myosins. Nature (London) 234, 81-85
2. Rayment, I., Rypniewski, W. R., Schmidt-Bäse, K., Smith, R., Tomchick, D. R., Benning, M. M., Winkelmann, D. A., Wesenberg, G., and Holden, H. M. (1993) Three-dimensional structure of myosin subfragment-1: a molecular motor. Science 261, 50-58
3. Mercadier, J. J., Bouveret, P., Gorza, L., Schiafino, S., Clark, W. A., Zak, R., Swynghedauw, B., and Schwartz, K. (1983) Myosin isoenzymes in normal and hypertrophied human ventricular myocardium. Circ. Res. 53, 52-62
4. Price, K. M., Littler, W. A., and Cummins, P. (1980) Human atrial and ventricular myosin light chain subunits in the adult and during development. Biochem. J. 191, 571-580
5. Morano, I. (1999) Tuning the human heart molecular motors by myosin light chains. J. Mol. Med. 77, 544-555
6. Sütsch, G., Brunner, U. T., Von Schulthess, C., Hirzel, H. O., Hess, O. M., Turina, M., Krayenbuehl, H. P., and Schaub, M. C. (1992) Hemodynamic performance and myosin light chain 1 expression in the hypertrophied left ventricle in aortic valve disease before and after valve replacement. Circ. Res. 70, 1035-1043
7. Morano, M., Zacharzowski, U., Maier, M., Lange, P. E., Alexi-Meskishvili, V., Haase, H., and Morano, I. (1996) Regulation of human heart by essential myosin light chain isoforms. J. Clin. Invest. 98, 467-473
8. Adelaziz, A.I., Segaric, J., Bartsch, H., Petzhold, D., Schlegel, W. P., Kott, M., Seefeldt, I., Klose, J., Bader, M., Haase, H., and Morano, I. (2004) Functional characterisation of the human atrial essential myosin light chain (hALC-1) in a transgenic rat model. J. Mol. Med., online 10.1007/s00109-004- 0525-4
9. Fewell, J. G., Hewett, T. E., Sanbe, A., Klevitsky, R., Hayes, E., Warshaw, D., Maughan, J., and Robbins, J. (1998) Functional significance of cardiac essential light chain isoform switching in transgenic mice. J. Clin. Invest. 101, 2630-2639
10. Ritter, O., Haase, H., Schulte, H. D., Lange, P. E., and Morano, I. (1999) Remodeling of the hypertrophied human myocardium by cardiac bHLH transcription factors. J. Cell. Biochem. 74, 551-561
11. Rotter, M., Zimmermann, K., Poustka, A., and Starzinski-Powitz, A. (1991) The human embryonic myosin light chain gene: use of alternative promoters and 3′non-coding regions. Nucleic Acids Res. 19, 1497-1504
12. Kimes, B. W., and Brandt, B. L. (1976) Properties of a clonal muscle cell line from rat heart. Exp. Cell Res. 98, 367-381
13. Molkentin, J. D., Lu, J. R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., and Olson, E. N. (1998) A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93, 215-228
14. Ritter, O., Hack, S., Schuh, K., Röthlein, N., Perrot, A., Osterziel, K.J., Schulte, H. D., and Neyses, L. (2002) Calcineurin in human heart hypertrophy. Circulation 105, 2265-2269
15. Passier, R., Zeng, H., Frey, N., Naya, F. J., Nicol, R. L., McKinsey, T. A., Overbeek, P., Richardson, J. A., Grant, S. R., and Olson, E. N. (2000) CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J. Clin. Invest. 105, 1395-1406
16. Zhang, T., Maier, L. S., Dalton, N. D., Miyamoto, S., Ross, J., Jr., Bers, D. M., and Brown, J. H. (2003) The delta C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure. Circ. Res. 92, 912-919
17. 2+/calmodulin-dependent protein kinase II delta-subunit isoforms in rats with hypertensive hypertrophy. Mol. Cell. Biochem. 220, 69-76
18. 2+/calmodulin-dependent protein kinas in failing and nonfailing human myocardium. Circ. Res. 84, 713-721
19. Bueno, O. F., De Windt, L. J., Tymitz, K. M., Witt, S. A., Kimball, T. R., Klevitsky, R., Hewett, T. E., Jones, S. P., Lefer, D. J., Peng, C. F., et al. (2000) The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic animals. EMBO J. 19, 6341-6350
20. Brostrom, M. A., Reilly, B. A., Wilson, F. J., and Crostrom, C. O. (2000) Vasopressin-induced hypertrophy in H9c2 heart-derived myocytes. Int. J. Biochem. Cell Biol. 32, 993-1006
21. 2+ and the protein kinase C-dependent activation pf p42 mitogen-activated protein kinase. Endocrinology 140, 1639-1648
22. Hoch, B., Haase, H., Schulze, W., Hagmann, D., Morano, I., Krause, E. G., and Karczewski, P. (1998) Differentiation-dependent expression of cardiac delta-CaMKII isoforms. J. Cell. Biochem. 68, 259-268
23. Tahara, A., Tomura, Y., Koh-ichi, W., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., and Tanaka, A. (1998) Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocytes. Cardiovasc. Res. 38, 198-205
24. Thibonnier, M. (1992) Signal transduction of V1-vascular vasopressin receptors. Regul. Pept. 38, 1-11
25. Davis, R. J. (1993) The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268, 14553-14556
26. Shaw, K. T. Y., Ho, A. M., Raghavan, A., Kim, J., Jian, J., Park, J., Sharma, S., Rao, A., and Hogan, P. G. (1995) Immunosuppressive drugs prevent a rapid dephosphorylation of transcription factor NFAT1 in stimulated immune cells. Proc. Natl. Acad. Sci. USA 92, 11205-11209
27. Molkentin, J. D., and Olson, E. N. (1997) GATA4: a novel transcriptional regulator of cardiac hypertrophy? Circulation 96, 3833-3835
28. 2+/CaM-dependent kinases: from activation to function. Annu. Rev. Pharmacol. Toxicol. 41, 471-505
29. Miyano, O., Kameshita, I., and Fujisawa, H. (1992) Purification and characterization of a brain-specific multifunctional calmodulin-dependent protein kinase from rat cerebellum. J. Biol. Chem. 267, 1198-1203
30. Lu, J., McKinsey, T. A., Nicol, R. L., and Olson, E. N. (2000) Signal-dependent activation of the MEF2 transcription factor by dissociation from histone deacetylases. Proc. Natl. Acad. Sci. USA 97, 4070-4075
31. 2+-regulated transcription factor phosphorylated by calmodulin-dependent kinases. Science 252, 1427-1430
32. 2+/calmodulin-dependent protein kinases involves phosphorylation of a negative regulatory site. Genes Dev. 8, 2527-2539
33. 2+/calmodulin-dependent protein kinases type I, II, and IV. J. Biol. Chem. 271, 3066-3073